File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Comparison of Intraoral Bone Regeneration with Iliac and Alveolar BMSCs

TitleComparison of Intraoral Bone Regeneration with Iliac and Alveolar BMSCs
Authors
Keywordsbioengineering
bone remodeling
bone substitutes
dental implants
osseointegration
tissue engineering
Issue Date2018
Citation
Journal of Dental Research, 2018, v. 97, n. 11, p. 1229-1235 How to Cite?
AbstractThis study compared the osteogenic potential of bone marrow mesenchymal stem cells (BMSCs) of iliac and alveolar origins (I-BMSCs and Al-BMSCs, respectively), which were transplanted in combination with β tricalcium phosphate (β-TCP) in peri-implant bone defects to investigate the osseointegration between dental implants and tissue-engineered bone in dogs. Specifically, I-BMSCs and Al-BMSCs were cultured, characterized, and seeded on β-TCP and subjected to immunoblotting analyses and alkaline phosphatase activity assays. Subsequently, these cell-seeded scaffolds were implanted into defects that were freshly generated in the mandibular premolar areas of 4 dogs. The defects were covered with β-TCP + Al-BMSCs (n = 6), β-TCP + I-BMSCs (n = 6), or β-TCP (n = 6) or served as the blank control (n = 6). After healing for 12 wk, the formation and mineralization of new bones were assessed through micro–computed tomographic, histologic, and histomorphometric analyses, and bone-to-implant contacts were measured in the specimens. It was evident that in this large animal model, I-BMSCs and Al-BMSCs manifested similarly strong osteogenic potential, as significantly more new bone was formed in the Al-BMSC and I-BMSC groups than otherwise (P < 0.01). Therefore, Al-BMSCs are emerging as an efficient alternative for autologous mesenchymal stem cells in regenerative dental and maxillofacial therapies. I-BMSCs, if not restricted in their bioavailability, can also be of great utility in bone tissue–engineering applications.
Persistent Identifierhttp://hdl.handle.net/10722/354118
ISSN
2023 Impact Factor: 5.7
2023 SCImago Journal Rankings: 1.909
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWang, F.-
dc.contributor.authorZhou, Y.-
dc.contributor.authorZhou, J.-
dc.contributor.authorXu, M.-
dc.contributor.authorZheng, W.-
dc.contributor.authorHuang, W.-
dc.contributor.authorZhou, W.-
dc.contributor.authorShen, Y.-
dc.contributor.authorZhao, K.-
dc.contributor.authorWu, Y.-
dc.contributor.authorZou, D.-
dc.date.accessioned2025-02-07T08:46:34Z-
dc.date.available2025-02-07T08:46:34Z-
dc.date.issued2018-
dc.identifier.citationJournal of Dental Research, 2018, v. 97, n. 11, p. 1229-1235-
dc.identifier.issn0022-0345-
dc.identifier.urihttp://hdl.handle.net/10722/354118-
dc.description.abstractThis study compared the osteogenic potential of bone marrow mesenchymal stem cells (BMSCs) of iliac and alveolar origins (I-BMSCs and Al-BMSCs, respectively), which were transplanted in combination with β tricalcium phosphate (β-TCP) in peri-implant bone defects to investigate the osseointegration between dental implants and tissue-engineered bone in dogs. Specifically, I-BMSCs and Al-BMSCs were cultured, characterized, and seeded on β-TCP and subjected to immunoblotting analyses and alkaline phosphatase activity assays. Subsequently, these cell-seeded scaffolds were implanted into defects that were freshly generated in the mandibular premolar areas of 4 dogs. The defects were covered with β-TCP + Al-BMSCs (n = 6), β-TCP + I-BMSCs (n = 6), or β-TCP (n = 6) or served as the blank control (n = 6). After healing for 12 wk, the formation and mineralization of new bones were assessed through micro–computed tomographic, histologic, and histomorphometric analyses, and bone-to-implant contacts were measured in the specimens. It was evident that in this large animal model, I-BMSCs and Al-BMSCs manifested similarly strong osteogenic potential, as significantly more new bone was formed in the Al-BMSC and I-BMSC groups than otherwise (P < 0.01). Therefore, Al-BMSCs are emerging as an efficient alternative for autologous mesenchymal stem cells in regenerative dental and maxillofacial therapies. I-BMSCs, if not restricted in their bioavailability, can also be of great utility in bone tissue–engineering applications.-
dc.languageeng-
dc.relation.ispartofJournal of Dental Research-
dc.subjectbioengineering-
dc.subjectbone remodeling-
dc.subjectbone substitutes-
dc.subjectdental implants-
dc.subjectosseointegration-
dc.subjecttissue engineering-
dc.titleComparison of Intraoral Bone Regeneration with Iliac and Alveolar BMSCs-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1177/0022034518772283-
dc.identifier.pmid29772189-
dc.identifier.scopuseid_2-s2.0-85047378515-
dc.identifier.volume97-
dc.identifier.issue11-
dc.identifier.spage1229-
dc.identifier.epage1235-
dc.identifier.eissn1544-0591-
dc.identifier.isiWOS:000445230700007-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats